{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:57:28Z","timestamp":1760029048417},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.pcad.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T00:45:45Z","timestamp":1510879545000},"page":"334-341","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Biomarkers in Mitral Regurgitation"],"prefix":"10.1016","volume":"60","author":[{"given":"Magnus","family":"B\u00e4ck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Pizarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Annick","family":"Clavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2017.11.004_bb0005","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"10.1016\/j.pcad.2017.11.004_bb0010","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2017.11.004_bb0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jtcvs.2015.04.009","article-title":"Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation","volume":"150","author":"Enriquez-Sarano","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pcad.2017.11.004_bb0020","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cjca.2014.07.014","article-title":"The role of biomarkers in valvular heart disease: focus on natriuretic peptides","volume":"30","author":"Bergler-Klein","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0025","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(09)60692-9","article-title":"Mitral regurgitation","volume":"373","author":"Enriquez-Sarano","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2017.11.004_bb0030","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/S0735-1097(03)00486-8","article-title":"Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation","volume":"41","author":"Sutton","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0035","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/01.CIR.0000164269.80908.9D","article-title":"B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome","volume":"111","author":"Detaint","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.11.004_bb0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.amjcard.2009.04.023","article-title":"Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation","volume":"104","author":"Potocki","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0045","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.amjcard.2005.11.085","article-title":"Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation","volume":"97","author":"Yusoff","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0050","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jacc.2009.06.013","article-title":"Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation","volume":"54","author":"Pizarro","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/heartjnl-2011-301128","article-title":"Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation","volume":"98","author":"Magne","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2017.11.004_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/eurjhf\/hfq189","article-title":"Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation","volume":"13","author":"Klaar","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.pcad.2017.11.004_bb0065","doi-asserted-by":"crossref","first-page":"e004451","DOI":"10.1161\/CIRCIMAGING.115.004451","article-title":"Synergistic utility of brain natriuretic peptide and left ventricular global longitudinal strain in asymptomatic patients with significant primary mitral regurgitation and preserved systolic function undergoing mitral valve surgery","volume":"9","author":"Alashi","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2017.11.004_bb0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.amjcard.2015.10.040","article-title":"Prognostic utility of brain natriuretic peptide in asymptomatic patients with significant mitral regurgitation and preserved left ventricular ejection fraction","volume":"117","author":"Mentias","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0075","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/eurjhf\/hfs114","article-title":"Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation","volume":"14","author":"Magne","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2017.11.004_bb0080","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jacc.2016.06.047","article-title":"Association of B-type natriuretic peptide with survival in patients with degenerative mitral regurgitation","volume":"68","author":"Clavel","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0085","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jacc.2012.12.044","article-title":"Brain natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction","volume":"61","author":"van Veldhuisen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0090","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.amjcard.2005.10.061","article-title":"Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation","volume":"97","author":"Detaint","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0095","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1510\/icvts.2010.263251","article-title":"No change in B-type natriuretic peptide levels assessed in the late postoperative period in patients with severe mitral regurgitation after mitral valve surgery","volume":"12","author":"Krishnaswami","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.pcad.2017.11.004_bb0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2143\/AC.60.3.2005008","article-title":"Plasma BNP levels are determined by the severity of left ventricular systolic dysfunction but not the types of underlying heart disease","volume":"60","author":"Wei","year":"2005","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0105","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.amjcard.2004.01.008","article-title":"Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation","volume":"93","author":"Mayer","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0110","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ahj.2008.01.003","article-title":"Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy","volume":"155","author":"Dini","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2017.11.004_bb0115","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/CIRCHEARTFAILURE.112.000174","article-title":"Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure","volume":"6","author":"Brenyo","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pcad.2017.11.004_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jjcc.2015.02.015","article-title":"B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy","volume":"66","author":"Kainuma","year":"2015","journal-title":"J Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijcard.2016.11.241","article-title":"Percutaneous mitral valve repair: the last chance for symptoms improvement in advanced refractory chronic heart failure?","volume":"228","author":"Berardini","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0130","doi-asserted-by":"crossref","first-page":"746","DOI":"10.4244\/EIJV10I6A128","article-title":"Clinical outcomes of MitraClip for the treatment of functional mitral regurgitation","volume":"10","author":"Taramasso","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.pcad.2017.11.004_bb0135","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/eurheartj\/ehv236","article-title":"Novel methodologies for biomarker discovery in atherosclerosis","volume":"36","author":"Hoefer","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2017.11.004_bb0140","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jprot.2013.10.009","article-title":"Proteomics discovery of biomarkers for mitral regurgitation caused by mitral valve prolapse","volume":"94","author":"Tan","year":"2013","journal-title":"J Proteomics"},{"key":"10.1016\/j.pcad.2017.11.004_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12014-015-9097-2","article-title":"New biomarkers for primary mitral regurgitation","volume":"12","author":"Deroyer","year":"2015","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.pcad.2017.11.004_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071120","article-title":"MicroRNAs in valvular heart diseases: potential role as markers and actors of valvular and cardiac remodeling","volume":"17","author":"Oury","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pcad.2017.11.004_bb0155","doi-asserted-by":"crossref","first-page":"e52442","DOI":"10.1371\/journal.pone.0052442","article-title":"Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions","volume":"8","author":"Vacchi-Suzzi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pcad.2017.11.004_bb0160","article-title":"Differential MicroRNA expression profile in myxomatous mitral valve prolapse and fibroelastic deficiency valves","volume":"17","author":"Chen","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pcad.2017.11.004_bb0165","first-page":"580","article-title":"Altered plasma MicroRNA expression in patients with mitral chordae tendineae rupture","volume":"25","author":"Bulent Vatan","year":"2016","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.pcad.2017.11.004_bb0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijcard.2016.07.179","article-title":"Circulating miR-148b-3p and miR-409-3p as biomarkers for heart failure in patients with mitral regurgitation","volume":"222","author":"Chen","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2017.11.004_bb0175","doi-asserted-by":"crossref","first-page":"14098","DOI":"10.3390\/ijms160614098","article-title":"Expression profiling of circulating MicroRNAs in canine myxomatous mitral valve disease","volume":"16","author":"Li","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.pcad.2017.11.004_bb0180","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/ATVBAHA.117.309566","article-title":"Circulating MicroRNA-125b predicts the presence and progression of uremic vascular calcification","volume":"37","author":"Chao","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003306201730155X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003306201730155X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T00:56:42Z","timestamp":1535245002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003306201730155X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S003306201730155X"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2017.11.004","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in Mitral Regurgitation","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}